Graft-versus-myeloma effect following antithymocyte globulin-based reduced intensity conditioning allogeneic stem cell transplantation.
Mohty M, Boiron JM, Damaj G, Michallet AS, Bay JO, Faucher C, Perreau V, Bilger K, Coso D, Stoppa AM, Tabrizi R, Gastaut JA, Michallet M, Maraninchi D, Blaise D.
Mohty M, et al. Among authors: faucher c.
Bone Marrow Transplant. 2004 Jul;34(1):77-84. doi: 10.1038/sj.bmt.1704531.
Bone Marrow Transplant. 2004.
PMID: 15133485
Clinical Trial.